Janux Therapeutics, Inc. (JANX)
14.52
+0.11
(+0.76%)
USD |
NASDAQ |
May 22, 16:00
14.52
0.00 (0.00%)
After-Hours: 20:00
Janux Therapeutics Profit Margin (Quarterly) : -652.6% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 21.02% |
| Gilead Sciences, Inc. | 28.94% |
| ADMA Biologics, Inc. | 39.59% |
| ACADIA Pharmaceuticals, Inc. | 1.36% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -11.73% |
| Return on Assets | -11.13% |
| Return on Invested Capital | -11.47% |
| Gross Profit Margin (Quarterly) | 87.44% |
| Operating Margin (Quarterly) | -916.5% |
| Return on Net Operating Assets | -346.5% |